
Sia Daneshmand/LinkedIn
Apr 28, 2025, 17:31
Sia Daneshmand: 1-year outcomes from SunRISe-1 study shared for NMIBC
Sia Daneshmand, Urologic Oncology Fellowship Director at the University of Southern California and Director of Clinical Research at Keck Medicine of USC, shared a post on X:
“Joe Jacob presenting highly anticipated 1-year durability study from the SunRISe-1 study showing the excellent results. More options soon to be available for our NMIBC.”
More posts featuring Sia Daneshmand.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 28, 2025, 17:31
Apr 28, 2025, 17:07
Apr 28, 2025, 16:35